(Q42714552)

English

Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687).

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687). (English)
Robert D M Davies
Petra Johannesson
Magnus J Johansson
Pablo Morentin Gutierrez
Charles J O'Donnell
Annika U Petersson
Andrew V Turnbull

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit